Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AgeX Therapeutics, Inc. | Chief Executive Officer | Common Stock, $0.0001 par value | 42K | $24.8K | $0.59 | Mar 11, 2023 | Direct |
AgeX Therapeutics, Inc. | Chief Executive Officer | Restricted Stock Units | 0 | Mar 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AGE | AgeX Therapeutics, Inc. | Mar 11, 2023 | 3 | -$625 | 4 | Mar 14, 2023 | Chief Executive Officer |
AGE | AgeX Therapeutics, Inc. | Dec 11, 2022 | 3 | -$638 | 4 | Dec 13, 2022 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Sep 11, 2022 | 3 | -$608 | 4 | Sep 13, 2022 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Jun 11, 2022 | 3 | -$833 | 4 | Jun 14, 2022 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Mar 11, 2022 | 3 | -$887 | 4 | Mar 15, 2022 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Dec 11, 2021 | 3 | -$686 | 4 | Dec 14, 2021 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Sep 11, 2021 | 3 | -$1.08K | 4 | Sep 21, 2021 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Jun 11, 2021 | 3 | -$1.65K | 4 | Jun 15, 2021 | Chief Executive Officer, Director |
AGE | AgeX Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Chief Executive Officer, Director |